Featuring PASV Valve and Endexo technology, the BioFlo^TM PASV PICC is shown to reduce catheter occlusions by 78% ¹ and thrombus accumulation by 87% ².

1 Burns, D. Retrospective Analysis The Vanderbilt PICC service: Program, Program, Procedural and Patient Outcomes Success, Vanderbilt University. JAVA Vol.10 No. 42005

2 In vitro blood loop model test results demonstrated on average 87% less thrombus accumulation.

BioFlo is a trademark of AngioDynamics^® and is distributed by Kimal PLC  in the UK and Germany.